My watch list  


IUPAC name 6-[amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one
CAS number
PubChem 148193
SMILES CN1C=NC=C1C(C2=CC=C(C=C2)Cl) (C3=CC4=C(C=C3)N(C(=O) C=C4C5=CC(=CC=C5)Cl)C)N
Molecular formula C27H22Cl2N4O
Molar mass 489.39578
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Tipifarnib (Zarnestra) is a drug that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML).

The compound was discovered by and is under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C, with registration number R115777.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tipifarnib". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE